PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.\', \'Department of Microbiology and Immunology and.\', \'Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.\', \'Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.\', \'Department of Pathology and Laboratory Medicine and.\', \'Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA.\', \'Department of Pathology and.\', \'Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1172/jci.insight.148999148999
?:doi
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 34291736
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all